Q-omics provides the consensus-scored MCRIP2P2 profile across patient tissues and cancer cell-line models. MCRIP2P2 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MCRIP2P2 RNA expression shows 4,325 significant gene co-expression associations, with the highest sampling consensus in LUAD. Together, these results highlight STAD, and LUAD as cancer lineages where MCRIP2P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.